China Pharma Holdings (CPHI) Intangibles (2010 - 2026)

China Pharma Holdings (CPHI) has reported Intangibles for 17 consecutive years, with $38.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Intangibles rose 495.31% year-over-year to $38.3 million; the trailing twelve-month figure through Jun 2026 stood at $38.3 million (up 495.31% YoY), and the FY2025 full-year result was $24.1 million, up 105.69% from the prior year.
• Intangibles fell to $38.3 million in Q2 2026 per CPHI's latest filing, from $38.7 million in the prior quarter.
• Across five years, Intangibles topped out at $38.7 million in Q1 2026 and bottomed at $106788.0 in Q3 2022.
• Historically, Intangibles has averaged $8.8 million across 5 years, with a median of $4.4 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Intangibles plunged 97.95% in 2022, then surged 1437.96% in 2023.
• Over 5 years, Intangibles stood at $1.8 million in 2022, then jumped by 80.1% to $3.3 million in 2023, then soared by 259.62% to $11.7 million in 2024, then soared by 105.69% to $24.1 million in 2025, then soared by 59.21% to $38.3 million in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $38.3 million, $38.7 million, and $24.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.